The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...
Pharmaceutical Technology on MSN4d
EC approves MSD’s pneumococcal 21-valent conjugate CapvaxiveThe decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.
In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...
Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is injected into ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...
Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...
Antimicrobial resistance and serotypes in Streptococcus pneumoniae have been evolving with the widespread use of antibiotics and the introduction of pneumococcal conjugate vaccines (PCV).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback